Patient or physician preferences for decision analysis: The prenatal genetic testing decision

Medical Decision Making

Volumn 19, Issue 1, 1999, Pages 66-77

  Heckerling, Paul S ^a   Verp, Marion S ^b   Albert, Nancy ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b NONE

Author keywords

Decision analysis; Patient preferences; Physician preferences; Prenatal genetic testing

Indexed keywords

ADULT; ARTICLE; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PRENATAL DIAGNOSIS;

AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; DECISION SUPPORT TECHNIQUES; FEMALE; HUMANS; MODELS, THEORETICAL; PATIENT SATISFACTION; PHYSICIANS; PREGNANCY; QUESTIONNAIRES;

EID: 0032928114     PISSN: 0272989X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0272989X9901900109     Document Type: Article

References (49)

1. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis. N Engl J Med. 1989;320:609-17.
2. Canadian Collaborative CVS-Amniocentesis Clinical Trial Group. Multicentre randomized clinical trial of chorionic villus sampling and amniocentesis. Lancet. 1989;1:1-6.
3. Benn PA, Hsu LYF, Carlson A, Tannenbaum HL. The centralized prenatal genetics screening program of New York City. III. The first 7000 cases. Am J Med Genet. 1985;20:369-384.
4. NICHD CVS Study Group. Diagnostic accuracy in chorionic villus sampling (CVS): initial findings from the U.S. Collaborative Study. Am J Hum Genet. 1988;43:A242.
5. Leschot NJ, Wolf H, Verjaal M, et al. Chorionic villi sampling: cytogenetic and clinical findings in 500 pregnancies. Br Med J. 1987;295:407-10.
6. Robinson GE, Garner DM, Olmstead MP, Shime J, Hutton EM, Crawford BM. Anxiety reduction after chorionic villus sampling and genetic amniocentesis. Am J Obstet Gynecol. 1988;159:953-6.
7. Spencer JW, Cox DN. Emotional responses of pregnant women to chorionic villi sampling or amniocentesis. Am J Obstet Gynecol. 1987;157:1155-60.
8. Spencer JW, Cox DN. A comparison of chorionic villi sampling and amniocentesis: acceptability of procedure and maternal attachment to pregnancy. Obstet Gynecol. 1988;72: 714-8.
9. Peterson WF, Berry FN, Grace MR, Gulbranson CL. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol. 1983;62:185-90.
10. Burnhill MS. Reducing the morbidity of vacuum abortion. In: Zatuchni GI, Sciarra JJ, Speidel JJ (eds). Pregnancy Termination: Procedures, Safety, and New Developments. Hagerston, PA: Harper & Row, 1979:136-48.
11. Callen DF, Korban G, Dawson D, et al. Extra embryonic/fetal karyotypic discordance during diagnostic chorionic villus sampling. Prenat Diagn. 1988;8:453-60.
12. Firth HV, Boyd PA, Chamberlain P, MacKenzie IZ, Lindenbaum RH, Huson SM. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet. 1991; 37:762-4.
13. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry, 1992-1994. Lancet, 1996;347:489-94.
14. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med. 1987;316:250-8.
15. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical Decision Analysis. Philadelphia, PA: W. B. Saunders, 1980.
16. Heckerling PS, Verp MS, Hadro TA. Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model. J Clin Epidemiol. 1994;11:1215-28.
17. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis. 1987;40:593-600.
18. Heckerling PS, Verp MS. Amniocentesis or chorionic villus sampling for prenatal genetic testing: a decision analysis. J Clin Epidemiol. 1991;44:657-70.
19. Heckerling PS, Verp MS. A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing. Med Care. 1994;32:863-80.
20. Hook EB, Cross PK, Schreinmachers DM. Chromosomal abnormality rates at amniocentesis and in live born infants. JAMA. 1983;249:2034-38.
21. Hook EB, Cross PK, Jackson L, Pergament E, Brambati B. Maternal age-specific rates of 47, +21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observation at amniocentesis. Am J Hum Genet. 1988;42:797-807.
22. Hook EB. Evaluation and projection of rates of chromosome abnormalities in chorionic villus studies (CVS). Am J Hum Genet. 1988;43:A108.
23. Wilson RD, Kedrick V, Wittman BK, McGillivray B. Spontaneous abortion and pregnancy outcome after normal first-trimester ultrasound examination. Obstet Gynecol 1986;67: 352-55.
24. Gilmore DH, McNay MB. Spontaneous fetal loss in early pregnancy. Lancet. 1985;1:107.
25. Olney RS, Khoury MJ, Alo CJ, et al. Increased risk for transverse digital deficiency after chorionic villus sampling: results of the United States Multistate case-control study, 1988-1992. Teratology. 1995;51:20-9.
26. Halliday J, Lumley J, Lyndsey W. Comparison of women who do and do not have amniocentesis or chorionic villus sampling. Lancet. 1995;345:704-9.
27. Torrance GW. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5:1-30.
28. Hollenberg JP. SMLTREE Version 2.6, 1988.
29. Payne JP, Bettman JR, Johnson EJ. Adaptive strategy selection in decision making. J Exp Psychol Learn Mem Cogn. 1988;14:534-52.
30. Einhorn HJ, Hogarth RM. Unit weighting schemes for decision making. Organ Behav Hum Perform. 1975;13:171-92.
31. Tversky A. Elimination by aspects: a theory of choice. Psychol Rev. 1972;79:281-9.
32. Simon HA. A behavioral model of rational choice Q J Econ. 195;69:99-118.
33. Tversky A. Intransitivity of preferences. Psychol Rev. 1969;76: 31-48.
34. Feinstein AR. The chagrin factor and qualitative decision making. Arch Intern Med. 1985;145:1257-9.
35. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley and Sons, 1989.
36. Zeger SL, Liang K-Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-30.
37. Hsieh FY. Sample size tables for logistic regression. Stat Med. 1989;8:795-802.
38. Slovic P, Fischoff B, Lichtenstein S. Behavioral decision theory. Annu Rev Psychol. 1977;28:1-39.
39. Einhorn H, Hogarth R. Behavioral decision theory: processes of judgment and choice. Annu Rev Psychol. 1981;32:53-88.
40. Boyd NS, Sutherland HJ, Heasman KZ, Tritchler DL, Cummings BJ. Whose utilities for decision analysis? Med Decis Making. 1990;10:58-67.
41. Holmes MM, Rovner DR, Rothert ML, et al. Women's and physicians' utilities for health outcomes in estrogen replacement therapy. J Gen Intern Med. 1987;2:178-82.
42. Svenson O, Benthorn LJ. Consolidation processes in decision making: post-decision changes in attractiveness of alternatives. J Econ Psychol. 1992;13:315-27.
43. Keeny RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Tradeoffs. New York: John Wiley and Sons, 1976.
44. Reed JL, Quinn RJ, Berwick DM, Fineberg HV, Weinstein MC. Preferences for health outcomes: comparison of assessment methods. Med Decis Making. 1984;4:315-29.
45. Bosch JL, Hunink MGM. The relationship between descriptive and valuational quality-of-life measures in patients with intermittent claudication. Med Decis Making. 1996;16:217-25.
46. Pauker SP, Pauker SG. Prenatal diagnosis: a directive approach to genetic counseling using decision analysis. Yale J Biol Med. 1977;50:275-89.
47. McCormack MJ, Rylance ME, Mackenzie WE, Newton J. Patients' attitudes following chorionic villus sampling. Prenat Diagn. 1990;10:253-5.
48. Heckerling PS, Verp MS. Genetic testing and early versus late prenatal testing. Lancet. 1991;337:363.
49. Pauker SP, Pauker SG. The amniocentesis decision: ten years of decision analytic experience. In: Evers-Kiebooms G, Cassiman J-J, Van den Berghe H, d'Ydewalle G (eds). Genetic Risk, Risk Perception, and Decision Making. Birth Defects: Original Article Series 23. New York: Alan R. Liss, 1987;151-69.